Form 4: Crinetics Pharmaceuticals COO Jeff Knight Executes Stock Option, Sells Shares

Crinetics Pharmaceuticals' Chief Operating Officer, Jeff E. Knight, exercised stock options and sold shares in the open market on March 22, 2024.

Summary

• On March 22, 2024, Jeff E. Knight, the Chief Operating Officer of Crinetics Pharmaceuticals, exercised stock options to acquire 30,000 shares of common stock at a price of $23.98 per share.
• Simultaneously, Knight sold 30,000 shares in the open market at a weighted average price of $44.22 per share, with prices ranging from $44.00 to $44.52.
• He also sold an additional 2,359 shares at $45.39 per share.
• Following these transactions, Knight directly owns 52,580 shares of Crinetics Pharmaceuticals common stock and holds options for 130,000 shares.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The exercise of stock options demonstrates the executive's confidence in the company's future prospects.
• The sale of shares provides the executive with personal financial gains.

Negatives

• The sale of shares by a high-ranking officer could be interpreted negatively by some investors, although it is a common practice.

Risks

• Executive stock sales can sometimes create short-term price volatility.
• There is always a risk that investors may misinterpret the reasons behind the stock sale.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. They are often scrutinized by investors for insights into management's perspective on the company's valuation and future prospects. Form 4 filings are a standard part of regulatory compliance for insider trading.

Comparison to Industry Standards

• Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
• The vesting schedule of the options (25% initially, then monthly) is a typical arrangement.
• The sale of shares after exercising options is a common practice for executives to realize the value of their compensation.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the potential for short-term price fluctuations.
• The transactions provide insight into executive compensation and ownership.

Key Dates